ARQIS has advised biotech company Emergence Therapeutics AG on the deal, while Horn&Co. advised Pontifax Ventures 6. J&A advised Bpifrance. Weitnauer advised NRW.BANK. The round was...
You must be a Standard 1 Year member to access this content.
ARQIS advised BME Group on the deal. BME Group acquired Heinrichs Fliesenmarkt in Northern Germany. The acquisition further builds out BME Group´s tiles competencies in Germany,...
You must be a Standard 1 Year member to access this content.
ARQIS advised Megger on the deal. Friedrich Graf von Westphalen & Partner advised IPS Intelligent Process Solutions the CEO, Dr. Zeljko Schreiner. The Megger Group announced...
You must be a Standard 1 Year member to access this content.
ARQIS appoints two new partners from its own ranks as of 1st January 2022. Dr. Friedrich Gebert will become a partner in the Risk focus group, while Dr....
You must be a Standard 1 Year member to access this content.
ARQIS continues to focus on growth. As part of the implementation of its new law firm strategy, ARQIS is strengthening itself with public lawyer Dr. Friedrich...
You must be a Standard 1 Year member to access this content.
